SAVA Q2 2022 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$17M

Operating Income

-$20M

Net Income

-$19M

EPS (Diluted)

$-0.46

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$13M

Stock-Based Comp.

$485,000

Balance Sheet

Total Assets

$227M

Total Liabilities

$9M

Stockholders' Equity

$218M

Cash & Equivalents

$197M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$17M	-$4M	-334.5%
Operating Income	-$20M	-$5M	-287.6%
Net Income	-$19M	-$5M	-277.1%